Prevalence and factors associated with statin use in high-risk patients with type 1 diabetes from a specialized diabetes unit

Amor, 2015, Clinical status of a cohort of patients with type 1 diabetes diagnosed more than 2 decades before Results of a specific clinical follow-up program, Endocrinol y Nutr., 63, 339, 10.1016/j.endonu.2016.03.008 Rawshani, 2017, Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes, N Engl J Med., 376, 1407, 10.1056/NEJMoa1608664 Rawshani, 2018, Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study, Lancet., 392, 477, 10.1016/S0140-6736(18)31506-X Lind, 2014, Glycemic Control and Excess Mortality in Type 1 Diabetes, N Engl J Med., 371, 1972, 10.1056/NEJMoa1408214 Gimenez, 2011, Repeated Episodes of Hypoglycemia as a Potential Aggravating Factor for Preclinical Atherosclerosis in Subjects With Type 1 Diabetes, Diabetes Care., 34, 198, 10.2337/dc10-1371 Bebu, 2017, The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study, Diabetologia., 60, 2084, 10.1007/s00125-017-4374-4 Pease, 2018, Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA), Cardiovasc Diabetol., 17, 77, 10.1186/s12933-018-0726-8 Rawshani, 2017, Range of Risk Factor Levels: Control Mortality, and Cardiovascular Outcomes in Type 1 Diabetes Mellitus, Circulation., 135, 1522, 10.1161/CIRCULATIONAHA.116.025961 Dorsey, 2018, Al. E. Standards of Medical Care in Diabetes—2018, Diabetes Care, 41, S55, 10.2337/dc18-S006 Jellinger, 2017, American Association. O.f. Clinical. Endocrinologists. A.n.d. American. College. O.f. Endocrinology. Guidelines for management of dyslipidemia and prevention of cardiovascular disease, Endocr Pract., 23, 1, 10.4158/EP171764.APPGL Piepoli, 2016, 2016 European Guidelines on cardiovascular disease prevention in clinical practice, Eur Heart J., 37, 2315, 10.1093/eurheartj/ehw106 NICE. Cardiovascular disease: risk assessment and reduction, including lipid modification Guidance and guidelines NICE. 2014. https://www.nice.org.uk/guidance/cg181/chapter/1-Recommendations#lipid-modification-therapy-for-the-primary-and-secondary-prevention-of-cvd-2. Accessed July 7, 2016. Gæde, 2003, Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes, N Engl J Med., 348, 383, 10.1056/NEJMoa021778 Cholesterol Treatment Trialists’ (CTT) Collaborators, Mihaylova B, Emberson J, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet (London, England). 2012;380(9841):581-590. Cholesterol Treatment Trialists’ (CTT) Collaborators CTT (CTT), Kearney PM, Blackwell L, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet (London, England). 2008;371(9607):117-125. Hero, 2016, Association Between Use of Lipid-Lowering Therapy and Cardiovascular Diseases and Death in Individuals With Type 1 Diabetes, Diabetes Care., 39, 996, 10.2337/dc15-2450 Ortega, 2015, [Cardiovascular disease in patients with type 1 and type 2 diabetes in Spain.], Med Clin (Barc)., 145, 233, 10.1016/j.medcli.2014.10.017 Lyons, 2018, Dyslipidemia and statin use in youth and adults ages 10-<40 years in the T1D Exchange Clinic Registry, Diabetes Obes Metab. July Weinstock, 2016, Type 1 diabetes in older adults: Comparing treatments and chronic complications in the United States T1D Exchange and the German/Austrian DPV registries, Diabetes Res Clin Pract., 122, 28, 10.1016/j.diabres.2016.09.024 2017, Glucose Concentrations of Less Than 3.0 mmol/L (54mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes: Table 1, Diabetes Care., 40, 155, 10.2337/dc16-2215 Jansa, 2015, Análisis psicométrico de las versiones en lengua castellana y catalana de un cuestionario de percepción de la hipoglucemia, Med Clin (Barc)., 144, 440, 10.1016/j.medcli.2013.11.036 Stone, 2014, et al., 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Circulation., 129, S1, 10.1161/01.cir.0000437738.63853.7a Swasey, 2018, Trends in cardiovascular risk factor management in type 1 diabetes by sex, J Diabetes Complications., 32, 411, 10.1016/j.jdiacomp.2018.01.003 Diabetes Control, 2016, Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Risk Factors for Cardiovascular Disease in Type 1 Diabetes. Diabetes., 65, 1370 Diabetes Control, 2016, (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up, Diabetes Care., 39, 686, 10.2337/dc15-1990 Amor, 2016, Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis, Atherosclerosis., 247, 161, 10.1016/j.atherosclerosis.2016.02.014 Carbonell, 2018, Diabetic retinopathy is associated with the presence and burden of subclinical carotid atherosclerosis in type 1 diabetes, Cardiovasc Diabetol., 17, 66, 10.1186/s12933-018-0706-z Vistisen, 2016, Prediction of first cardiovascular disease event in type 1 diabetes mellitus the steno type 1 risk engine, Circulation., 133, 1058, 10.1161/CIRCULATIONAHA.115.018844 Livingstone, 2015, Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes 2008-2010, JAMA., 313, 37, 10.1001/jama.2014.16425 Colom, 2015, Control glucémico y complicaciones crónicas a 20 años del comienzo de la diabetes tipo 1 Resultados de una unidad especializada, Av en Diabetol., 31, 113, 10.1016/j.avdiab.2015.02.002 Timmis, 2018, European Society of Cardiology: Cardiovascular Disease Statistics 2017, Eur Heart J., 508, 10.1093/eurheartj/ehx628